No Data
Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Insider Purchase: Chief Executive Officer of $RGLS Buys 50,000 Shares
Regulus Therapeutics Kidney Disease Treatment Shows Response in Early-stage Trial -- Shares Fall
Regulus Stock Tumbles 24% Amid Study, Regulatory Updates
Regulus Therapeutics Provides Positive Clinical And Regulatory Updates For ADPKD Program
Regulus Therapeutics Shares Are Trading Higher After the Company Announced Positive Topline Clinical Data and Regulatory Updates From Its ADPKD Program.
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
104687047 : Thank you for your hardwork. Also very good choice to remove your top picks. People should do their own DD and not copy trades like those scam gurus out there
Jaguar8 OP 104687047 : yup so they will decide which one
72812736 : Thank you for your hard and selfless contributions all this time!!!!![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Dreaming Cat : Thank you for your hard work Sir
Lynn953818 : thank you very much
View more comments...